|
Category: pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | white powder (est) |
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 121.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 447.15 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 3.590000 mmHg @ 25.00 °C. (est) |
| Flash Point: | 332.00 °F. TCC ( 166.70 °C. ) (est)
|
| logP (o/w): | 3.870 |
| Soluble in: |
| | water, 8.81 mg/L @ 25 °C (exp) | | | water, 5.003 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intravenous-mouse LDLo 100 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: DYSPNEA
BEHAVIORAL: ATAXIA Journal of Medicinal Chemistry. Vol. 11, Pg. 117, 1968.
intraperitoneal-rat LD50 327 mg/kg Drugs in Japan Vol. -, Pg. 1183, 1995.
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | pharmaceuticals / chemical synthisis |
| Recommendation for progesterone usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for progesterone flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
| EPI System: | View |
| ClinicalTrials.gov: | search |
| Daily Med: | search |
| Chemical Carcinogenesis Research Information System: | Search |
| AIDS Citations: | Search |
| Cancer Citations: | Search |
| Toxicology Citations: | Search |
| EPA GENetic TOXicology: | Search |
| EPA Substance Registry Services (TSCA): | 57-83-0 |
| EPA ACToR: | Toxicology Data |
| EPA Substance Registry Services (SRS): | Registry |
| Laboratory Chemical Safety Summary : | 5994 |
| National Institute of Allergy and Infectious Diseases: | Data |
| WGK Germany: | 3 |
| | (8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
| Chemidplus: | 0000057830 |
| EPA/NOAA CAMEO: | hazardous materials |
| RTECS: | TW0175000 for cas# 57-83-0 |
References:
| | (8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 5994 |
| Pubchem (sid): | 134971194 |
Other Information:
| (IUPAC): | Atomic Weights of the Elements 2011 (pdf) |
| Videos: | The Periodic Table of Videos |
| tgsc: | Atomic Weights use for this web site |
| (IUPAC): | Periodic Table of the Elements |
| CHEBI: | View |
| CHEMBL: | View |
| Golm Metabolome Database: | Search |
| Metabolomics Database: | Search |
| KEGG (GenomeNet): | C00410 |
| HMDB (The Human Metabolome Database): | HMDB01830 |
| FooDB: | FDB001871 |
| Export Tariff Code: | 2937.92.8020 |
| MedlinePlusSupp: | View |
| VCF-Online: | VCF Volatile Compounds in Food |
| ChemSpider: | View |
| Wikipedia: | View |
Formulations/Preparations: •progesterone is available in an oily solution for injection, as pessaries or suppositories and as an intrauterine device.
•prochieve is available in two strengths: 4% gel (45 mg of progesterone) and 8% gel (90 mg of progesterone).
•progesterone injection, (projestaject, others) contains 25 to 100 mg progesterone per ml of vegetable oil. aqueous suspensions of progesterone are particularly painful & are seldom used. progesterone is also available in a t-shaped intrauterine contraceptive device that provides continuous delivery of progesterone in the uterine cavity for 1 yr. this is marketed under the name of progestasert and contains 38 mg of progesterone.
•vials (aqueous solution and in oil), 25 mgml, 50 mgml, and 100 mgml. intrauterine system, 38 mg, provides contraceptive effectiveness for a period of one year.
•grade: national formulary
•progesterone exists in two crystalline forms (alpha- and beta-) of equal physiological activity.
•alza corp...developed and intrauterine device, progestasert, designed to release progesterone by diffusion through a rate-controlling membrane for up to one year.
|
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| (8S,9S,10R,13S,14S,17S)-17- | acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | | | agolutin | | | akrolutin | | | bio-luton | | | colprosterone | | | corlutin | | | corluvite | | | corporin | | | crinone | | | cyclogest | | | duraprogen | | | endometrin | | | estima | | | flavolutan | | | fologenon | | | gesterol 100 | | | gesterol 50 | | | gestiron | | | gestone | | | gestormone | | | gestron | | | glanducorpin | | | gynlutin | | | gynoluton | | | hormoflaveine | | | hormoluton | | | lingusorbs | | | lipolutin | | | lucorteum | | | lugesteron | | | luteodyn | | | luteol | | | luteosan | | | luteostab | | | luteovis | | | luteum | | | lutociclina | | | lutocuclin M | | | lutocyclin | | | nalutron | | | percutacrine | | | piaponon | | | pregn-4-en-3,20-dione | | (S)- | pregn-4-en-3,20-dione | | | pregn-4-ene-3,20-dione | | 4- | pregnen-3,20-dione | | (S)-4- | pregnene-3,20-dione | | | progeffik | | | progestan | | | progestasert | | (S)- | progesterone | | | progestogel | | | progestol | | | prontogest | | | syngesterone | | | synovex S | | | utrogest | | | vitarrine |
Articles:
|